Biorem (FRA:R6D) Beginning Cash Position: €6.18 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:R6D Biorem Inc FRA:R6D
88 GF Score
Price €2.06
GF Value €1.97
! 2 Warning Signs
View Full Analysis

What is Biorem Beginning Cash Position?

Biorem FRA:R6D 88 Beginning Cash Position is €6.18 Mil as of Jun. 2026. GuruFocus rates FRA:R6D with a GF Score™ of 88/100 and a GF Value™ of €1.97. The stock has 2 warning signs investors should review.

Biorem's Beginning Cash Position for the quarter that ended in Jun. 2026 was €6.18 Mil.

Biorem's quarterly Beginning Cash Position increased from Dec. 2025 (€5.17 Mil) to Mar. 2026 (€7.25 Mil) but then declined from Mar. 2026 (€7.25 Mil) to Jun. 2026 (€6.18 Mil).

Biorem's annual Beginning Cash Position declined from Dec. 2023 (€2.58 Mil) to Dec. 2024 (€1.54 Mil) but then increased from Dec. 2024 (€1.54 Mil) to Dec. 2025 (€3.23 Mil).


Biorem Beginning Cash Position Related Terms


Biorem Beginning Cash Position Historical Data

* Premium members only.

The historical data trend for Biorem's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biorem Beginning Cash Position Chart

Biorem Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beginning Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.13 3.11 2.58 1.54 3.23

Biorem Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.09 4.72 5.17 7.25 6.18
FRA:R6D
88GF Score
Biorem Inc FRA:R6D
Beginning Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Biorem Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

What does a Beginning Cash Position of €6.18 Mil mean?
Biorem (FRA:R6D) has a Beginning Cash Position of €6.18 Mil as of Jun. 2026. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Biorem and its competitors.
Is Biorem's Beginning Cash Position too high?
Biorem's current Beginning Cash Position is €6.18 Mil. Overall, Biorem has a GF Score™ of 88/100, reflecting its overall financial health beyond just this single metric.
How does Biorem's Beginning Cash Position compare to VLTO and ZWS?
Biorem's Beginning Cash Position of €6.18 Mil can be compared against companies in the Industrial Products industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beginning Cash Position for an Industrial Products company?
A good Beginning Cash Position depends on the Industrial Products industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beginning Cash Position mean?
A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Biorem and its competitors. Biorem's current Beginning Cash Position is €6.18 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biorem stock overvalued right now?
Biorem (FRA:R6D) has a current Beginning Cash Position of €6.18 Mil. The stock's GF Value™ is €1.97, compared to a current price of €2.06 — trading 4.6% above its estimated fair value. The current Beginning Cash Position is €6.18 Mil. Biorem's overall GF Score™ is 88/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beginning Cash Position calculated?
Beginning Cash Position is calculated from a company's financial statements. For Biorem (FRA:R6D), the current Beginning Cash Position is €6.18 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Biorem (FRA:R6D) Overvalued in 2026?

Based on GuruFocus' analysis, Biorem stock appears to be overvalued. The current stock price of €2.06 is trading 4.6% above its estimated GF Value™ of €1.97.

Key valuation signals for FRA:R6D:

  • Beginning Cash Position: €6.18 Mil
  • GF Value™: €1.97 vs. price of €2.06 (4.6% above fair value)
  • GF Score™: 88/100 with 2 warning signs

No single metric tells the full story. See the FRA:R6D stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Biorem Business Description

Other Exchanges BIRMF:USABRM:Canada
Address 7496 Wellington Road 34, RR Number 3, Puslinch, Guelph, ON, CAN, N1H 6H9
Biorem Inc is an environmental biotechnology company. It is involved in the manufacturing of a comprehensive line of high efficiency air pollution control systems that are used to eliminate odorous and harmful contaminants. The company's products include Biofilters, Biogas Solutions, Multi-Stage Systems, Biotrickling filters, and services such as Media Sampling and Analysis, Biological processes and testing, Media replacements and Spare parts, and other related services. The company derives revenues from the sale of standard products, construction projects for specialized products, and services for repairs and maintenance. The group has a business presence in Canada, the United States, China and others, of which key revenue is derived from the United States.
88GF Score

Get the complete analysis for FRA:R6D

Beginning Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.06
Price
€1.97
GF Value